FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

4d ago

BIIB

PremiumPress Releases

Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel

11d ago

BIIB

PremiumPress Releases

Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

15d ago

BIIB

PremiumPress Releases

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

23d ago

BIIB

PremiumPress Releases

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis

29d ago

BIIB

PremiumPress Releases

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

1M ago

BIIB

More BIIB News >

BIIB News on the Web

2024-06-13

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune

Yahoo Finance

Neutral

2024-06-12

4 Best Stocks to Buy and 3 Best Stocks to Sell: June 2024

InvestorPlace

Neutral

2024-06-12

Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab

Yahoo Finance

Neutral

2024-06-11

Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug

CNBC

Neutral

2024-06-11

A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club

CNBC

Neutral

2024-06-11

Here's an undervalued stock that can benefit from new Alzheimer's drugs

CNBC

Neutral

2024-06-11

Eli Lilly Alzheimer's Drug Donanemab Gets FDA Panel Nod

Yahoo Finance

Neutral

2024-06-11

Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod

Zacks

Neutral

News Score - Last 7 Days

Positive

BIIB

Sector Average

Media Buzz

This Week17 articles

Weekly Average18.5 articles

News Sentiment

This Week100%

Sector Average61%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BIIB’s Media Buzz Sentiment?

17 articles about BIIB were published this week. In an average week, 18.5 articles are published.

What is BIIB’s weekly average amount of articles?

In an average week, 18.5 articles about BIIB are published.

What is BIIB’s News Sentiment?

100% of articles about BIIB were positive this week, compared to its sector average of 61%.

Healthcare Stocks that are Trending in the News

2367Giant Biogene Holding Co. Ltd.

MXCTMaxCyte

VRDNViridian Therapeutics

ALURAllurion Technologies

MCKMcKesson

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing